Skip to main content
SpringerLink
Log in

Antineoplastic therapy for stage IV NSCLC in elderly patients is `far from consistent',

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antineoplastic therapy for stage IV NSCLC in elderly patients is `far from consistent',. Pharmacoecon. Outcomes News 271, 6 (2000). https://doi.org/10.1007/BF03275529

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03275529

Keywords

Search

Navigation